http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201117764-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1fc6feb71e7888d72212f7ed6f4e46b9
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-24
filingDate 2009-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11610d188ee154665647316a55afe617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6de201dd4c16fc3d4d6e80da654dcca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_007969fa56fe769f5fe8474735ec357e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e322e8b45bbca509d1945c7164c19351
publicationDate 2011-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-201117764-A
titleOfInvention Ingestible therapy activator system and method
abstract An ingestible therapy activator system and method are provided. In one aspect, the ingestible therapy activator includes an ingestible device having an effector module to send instruction and a responder module associated with a therapeutic device. The responder module may receive and process the effector instruction, resulting in a response by the therapeutic device. Examples of responses by therapeutic device include activating a therapy, deactivating a therapy, modulating a therapy, and discontinuing a therapy.
priorityDate 2009-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78968
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5515

Total number of triples: 17.